Birdwatch Archive

Birdwatch Note Rating

2024-02-27 15:43:39 UTC - HELPFUL

Rated by Participant: D67DFAE64AC2D55045F57AE44A8B766B03443809893C1D7F22F3B116C53E7B2C
Participant Details

Original Note:

A two-shot course of Pfizer Inc.’s vaccine may have just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa. https://www.bloomberg.com/news/articles/2021-12-11/pfizer-course-has-23-efficacy-vs-omicron-in-s-african-study

All Note Details

Original Tweet

All Information

  • noteId - 1518288895741509633
  • participantId -
  • raterParticipantId - D67DFAE64AC2D55045F57AE44A8B766B03443809893C1D7F22F3B116C53E7B2C
  • createdAtMillis - 1709048619131
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1518288895741509633D67DFAE64AC2D55045F57AE44A8B766B03443809893C1D7F22F3B116C53E7B2C